Articles by Larissa Ku
Chinese GPs provide Series A for Mexican digital bank
Stori, a Mexican digital bank founded by a team with China backgrounds, has raised $10 million in an extended tranche of Series A led by Source Code Capital and Bertelsmann Asia Investments (BAI). Existing investor Vision Plus Capital also participated....
China technology training platform 51CTO raises $20m
51CTO, a Chinese online technology training platform, has raised $20 million in a Series C funding round led by Gaocheng Capital.
First responders: China VCs on a healthcare crisis
The coronavirus outbreak has thrust Chinese healthcare services into the spotlight, prompting investors to identify to sub-segments with potential for significant growth
China logistics player Yimidida raises $140m
Yimidida, a Chinese logistics platform has raised RMB1 billion ($140 million) in an extended tranche of Series D funding. The round took place in parallel with the firm’s acquisition of Shanghai-based UC Express.
HighLight hits $300m first close on China healthcare fund
Chinese healthcare-focused GP HighLight Capital has reached the first close of $300 million on its third US dollar-denominated fund, but further progress is likely to be delayed by the coronavirus outbreak.
China space tech: Aligning the stars
SpaceX-inspired global fervor about the possibilities of space technology has infiltrated China. Some start-ups appear well set for commercial lift-off, but many others will misfire
CICC raises $229m for China healthcare fund
China's CICC Capital has raised RMB1.6 billion ($229 million) for its first fund dedicated to the biopharmaceutical space.
Chinese fashion design platform raises $14m
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised RMB100 million ($14 million) in funding led by Gaorong Capital. Shunwei Capital, Vision Plus Capital, Baidu Ventures and Yinxinggu Capital also took part....
Chinese online insurance player raises $55m in US IPO
Huize Holding, a Shanghai-based insurance platform backed by SAIF Partners, has raised about $55 million in a US IPO.
China B2B platform Yijiupi raises new round, buys Zskuaixiao
Yijiupi, a Chinese B2B e-commerce platform that initially focused on liquor products, has acquired local B2B consumer goods distributor Zskuaixiao. It has also secured a new round of funding backed by several Zskuaixiao investors.
Chinese medical imaging business secures $86m Series B
Shanghai-based Universal Medical Imaging, China’s largest independent imaging diagnosis company has raised a RMB600 million ($86 million) Series B round led by Cathay Capital, V Star Capital and CEC Capital.
Schroders backs Singapore incubator Antler
Schroders has participated in a funding round for Singapore-headquartered incubator Antler that takes the company's total fundraising over the past six months to $75 million.
Deal focus: Lightspeed targets solid-state LiDAR
Having assessed some 40 autonomous driving companies globally, Lightspeed China Partners decided that Hesai - a business born in the US and raised in China - is best-placed to take the technology forwards
PE-backed Akeso Biopharma targets Hong Kong IPO
Chinese biotech player Akeso Biopharma has made a second attempt at filing for a Hong Kong IPO after its previous application was rejected last month for failing to meet regulatory requirements.
Japan's SBI seeks $920m for technology fund
SBI Investment has launched a technology-focused VC fund, known as 4+5 Fund, with a target of JPY100 billion ($920 million).
AVCJ Awards 2019: Deal of the Year - Small Cap: AffaMed Therapeutics
CBC Group established biosimilars specialist AffaMed Therapeutics to remove uncertainties in the development process and to tap Chinese demand for affordable treatments
Joy Capital leads $88m round for China's Shihuituan
Joy Capital has announced its participation - as the lead investor - in an $88.3m funding round for Chinese community group buying platform Shihuituan, which is also known as Nice Tuan.
Chinese genetic testing player for infectious diseases gets Series B+
Chinese genetic testing specialist Genskey raised an RMB50 million ($7.1m) extended Series B round of funding led by Shenzhen-based Fortune Capital. Existing investor Legend Capital re-upped.
Raffles Family Office backs Hong Kong co-working space player
Hong Kong-based multi-family office Raffles Family Office will invest $15 million in local co-working space operator WorkTech.
Centurium leads $100m Series D for China's Yunxuetang
Yunxuetang, an online corporate training services provider focused on China, has raised $100 million in Series D funding led by Centurium Capital. Existing investors Yunfeng Capital and SIG both re-upped.
Warburg Pincus returns $2b from China portfolio in 2019
Warburg Pincus generated distributions of $2 billion from its China investments last year, a record annual total for its local operation.
Profile: Joy Capital's Erhai Liu
First at Legend Capital and now at Joy Capital, Erhai Liu has demonstrated a knack for spotting emerging technology trends in China and helping founders navigate the challenges of entrepreneurialism
Green Pine leads Series B for Chinese gene testing player
Chinese gene testing business AmCare Genomics Lab has raised RMB110 million ($16 m) in Series B funding led by Green Pine Capital Partners. This comes four months after the company closed an extended Series A round of RMB30 million.
Centurium backs China logistics player
Centurium Capital has invested $300 million in ANE Logistics, one of the largest LTL (Less-than-truckload) operators in China.